|
|
|
|
|
|
|
|
|
|
|
|
Protein Info
|
|
|
|
|
|
Short Name:
|
MAP2K3
|
|
Full Name:
|
Dual specificity mitogen-activated protein kinase kinase 3
|
|
Alias:
|
EC 2.7.12.2; MAP kinase kinase 3; MAPK,ERK kinase 3; MAPK/ERK kinase 3; MAPKK 3; MEK3; MP2K3; PRKMK3
|
|
Type:
|
Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily
|
|
Mass (Da):
|
39318
|
|
Number AA:
|
347
|
|
UniProt ID:
|
P46734
|
|
International Prot ID:
|
IPI00220438
|
|
Sequence:
|
Retrieve full protein sequence
|
|
|
|
|
GO Terms
|
|
External Links
|
Internal Links
|
|
|
|
|
|
Cellular Component:
|
|
Uniprot
|
OncoNet
|
|
Molecular Function:
|
GO:0000166
GO:0003824
GO:0004672
|
PhosphoSite+
|
KinaseNET
|
|
|
Biological Process:
|
GO:0000165
GO:0000187
GO:0003008
|
Phosida
|
TranscriptoNet
|
|
|
|
|
STRING
|
Kinexus Products
MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 pan-specific antibody AB-NK101-4#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-NK101-4#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 pan-specific antibody AB-NK101-5#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-NK101-5#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 pan-specific antibody AB-NK101-6#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-NK101-6#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 S218 phosphosite-specific antibody AB-PK713#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK713#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 Y230 phosphosite-specific antibody AB-PK714#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK714#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (S46-A61, human) peptide - Powder PE-01AWB99#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-01AWB99#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (A311-F325, human) peptide - Powder PE-01AWC85#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-01AWC85#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (T333-S347, human) peptide - Powder PE-01AWD99#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-01AWD99#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-K221, human) pS218 phosphopeptide - Powder PE-04ABS99#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABS99#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (K228-P233, human) pY230 phosphopeptide - Powder PE-04ABT80#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABT80#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-P233, human) pS218+pT222+pY230 phosphopeptide - Powder PE-04AWI70#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWI70#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (V215-K221, human) pS218 phosphopeptide - Powder PE-04BAB00#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04BAB00
|
|
|
|
|
Info Box
|
|
A variety of parameters were considered in the selection of putative P-sites.
Confirmed P-Sites have lower Hydrophobicity Scores. The P-site Similarity Score
is lower the more that it resembles typical confirmed corresponding P-Ser, P-Thr
or P-Tyr sites. The Maximum KInase Score provides the calculated score for
highest match of 500 human protein kinases for the amino acid sequence
surrounding the target P-site as determined with Kinase Substrate Predictor V2.
The Sum KInase Score provides the additive sum of the positive individual Kinase
Substrate Predictor V2 scores from 500 human protein kinases. The Conservation
Score is the average of the percent similarity of the human P-site with the
equivalent P-site in 20 other diverse species. Click the coloured buttons below
to retrieve this and other information in the Info Box, or click the orange
buttons for relevant links. |
|
| Phosphosites | |
| |
| | | -7 | -6 | -5 | -4 | -3 | -2 | -1 | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | | Expt. conf. | Effect | Kinase | PPase | Kinexus Products | | Ref. | Evol. | Kinase Pred. | P-site Match |
| | Site 1 | S3 | _ | _ | _ | _ | _ | M | E | S | P | A | S | S | Q | P | A | |  |  | | | | |  | | | |
| | Site 2 | S6 | _ | _ | M | E | S | P | A | S | S | Q | P | A | S | M | P | | | | | | | | | | | |
| | Site 3 | S7 | _ | M | E | S | P | A | S | S | Q | P | A | S | M | P | Q | |  | | | | | | | | | |
| | Site 4 | S11 | P | A | S | S | Q | P | A | S | M | P | Q | S | K | G | K | | | | | | | | | | | |
| | Site 5 | S15 | Q | P | A | S | M | P | Q | S | K | G | K | S | K | R | K | | | | | | | | | | | |
| | Site 6 | S19 | M | P | Q | S | K | G | K | S | K | R | K | K | D | L | R | | | | | | | | | | | |
| | Site 7 | S28 | R | K | K | D | L | R | I | S | C | M | S | K | P | P | A | | | | | | | | | | | |
| | Site 8 | S31 | D | L | R | I | S | C | M | S | K | P | P | A | P | N | P | | | | | | | | | | | |
| | Site 9 | T39 | K | P | P | A | P | N | P | T | P | P | R | N | L | D | S | | | | | | | | | | | |
| | Site 10 | S46 | T | P | P | R | N | L | D | S | R | T | F | I | T | I | G | | | | | | | | | | | |
| | Site 11 | T48 | P | R | N | L | D | S | R | T | F | I | T | I | G | D | R | | | | | | | | | | | |
| | Site 12 | S68 | A | D | D | L | V | T | I | S | E | L | G | R | G | A | Y | | | | | | | | | | | |
| | Site 13 | Y75 | S | E | L | G | R | G | A | Y | G | V | V | E | K | V | R | | | | | | | | | | | |
| | Site 14 | T98 | A | V | K | R | I | R | A | T | V | N | S | Q | E | Q | K | | | | | | | | | | | |
| | Site 15 | S101 | R | I | R | A | T | V | N | S | Q | E | Q | K | R | L | L | | | | | | | | | | | |
| | Site 16 | Y151 | D | T | S | L | D | K | F | Y | R | K | V | L | D | K | N | | | | | | | | | | | |
| | Site 17 | S182 | R | A | L | E | H | L | H | S | K | L | S | V | I | H | R | | | | | | | | | | | |
| | Site 18 | S185 | E | H | L | H | S | K | L | S | V | I | H | R | D | V | K | | | | | | | | | | | |
| | Site 19 | S194 | I | H | R | D | V | K | P | S | N | V | L | I | N | K | E | | | | | | | | | | | |
| | Site 20 | S212 | K | M | C | D | F | G | I | S | G | Y | L | V | D | S | V | | | | | | | | | | | |
| | Site 21 | Y214 | C | D | F | G | I | S | G | Y | L | V | D | S | V | A | K | | | | | | | | | | | |
| | Site 22 | S218 | I | S | G | Y | L | V | D | S | V | A | K | T | M | D | A | | | | | |  MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 S218 phosphosite-specific antibody AB-PK713#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK713#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-K221, human) pS218 phosphopeptide - Powder PE-04ABS99#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABS99#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-P233, human) pS218+pT222+pY230 phosphopeptide - Powder PE-04AWI70#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWI70#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (V215-K221, human) pS218 phosphopeptide - Powder PE-04BAB00#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04BAB00 | | | | | |
| | Site 23 | T222 | L | V | D | S | V | A | K | T | M | D | A | G | C | K | P | | | | | | MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-P233, human) pS218+pT222+pY230 phosphopeptide - Powder PE-04AWI70#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWI70 | | | | | |
| | Site 24 | Y230 | M | D | A | G | C | K | P | Y | M | A | P | E | R | I | N | | | | | | MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3 Y230 phosphosite-specific antibody AB-PK714#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK714#MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-P233, human) pS218+pT222+pY230 phosphopeptide - Powder PE-04AWI70#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWI70 | | | | | |
| | Site 25 | Y245 | P | E | L | N | Q | K | G | Y | N | V | K | S | D | V | W | | | | | | | | | | | |
| | Site 26 | S249 | Q | K | G | Y | N | V | K | S | D | V | W | S | L | G | I | | | | | | | | | | | |
| | Site 27 | T273 | F | P | Y | E | S | W | G | T | P | F | Q | Q | L | K | Q | | | | | | | | | | | |
| | Site 28 | S286 | K | Q | V | V | E | E | P | S | P | Q | L | P | A | D | R | | | | | | | | | | | |
| | Site 29 | S295 | Q | L | P | A | D | R | F | S | P | E | F | V | D | F | T | | | | | | | | | | | |
| | Site 30 | T302 | S | P | E | F | V | D | F | T | A | Q | C | L | R | K | N | | | | | | | | | | | |
| | Site 31 | S315 | K | N | P | A | E | R | M | S | Y | L | E | L | M | E | H | | | | | | | | | | | |
| | Site 32 | Y316 | N | P | A | E | R | M | S | Y | L | E | L | M | E | H | P | | | | | | | | | | | |
|
|
|
|
|
|
|
|
Legend
|
|
|
|
Confirmed in mammals
|
|
Confirmed in related proteins or other species
|
|
|
Predicted by Kinexus P-Site Prediction algorithm
|
|
|
No data/link available
|
|
|
Link available
|
|
|
Products available
|
|
|
|
|
|
|